Trial Profile
Study of ustekinumab in psoriatic arthritis patients- a 24 month prospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2018 New trial record